Mortimer
Mortimer Korf-Klingebiel, Duderstadt DE
Patent application number | Description | Published |
---|---|---|
20150352186 | FACTOR 1 PROTEIN, FACTOR 2 PROTEIN AND INHIBITORS THEREOF FOR USE IN TREATING OR PREVENTING DISEASES - The present invention relates to proteins comprising amino acid sequences encoded by nucleic acids derived from the human chromosomal region C19Orf10 termed Factor1 and/or C19Orf63 termed Factor 2 for the use in enhancing proliferation and/or healing and/or inhibiting apoptosis of none-transformed tissue or none-transformed cell or inhibitors thereof. The invention further relates to the use of inhibitors of factor1 and factor 2 for medical use, preferably for use in treating or preventing a disease in which angiogenesis contributes to disease development or progression. | 12-10-2015 |
Mortimer Mamelak, Toronto, ON CA
Patent application number | Description | Published |
---|---|---|
20090215890 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR AMINO ACID CARRIERS - The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs. | 08-27-2009 |
20100022643 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR AMINO ACID CARRIERS - The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs. | 01-28-2010 |
20130324759 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR AMINO ACID CARRIERS - The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs. | 12-05-2013 |
Mortimer Poncz, Wynnewood, PA US
Patent application number | Description | Published |
---|---|---|
20080317761 | Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage - A pharmaceutical composition comprises a therapeutic peptide or protein, a transport moiety capable of transporting said first peptide or protein into a hematopoietic cell differentiated from a common myeloid progenitor, and a linker between said first protein and said transport moiety, said linker susceptible to cleavage by an intracellular enzyme in the cell. A cell or collection of cells, e.g., platelets, containing such a composition is useful in methods for treating infection, inflammation, vascular injuries or any disorders involving or mediated by cells of the hematopoietic lineage. Methods of making such compostions are also disclosed. | 12-25-2008 |
Mortimer Poncz, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20140086883 | Compositions and Methods for the Generation of Platelets and Methods of Use Thereof - Compositions and methods for generating platelets and methods of use thereof are disclosed. | 03-27-2014 |
Mortimer Poncz, Narbeth, PA US
Patent application number | Description | Published |
---|---|---|
20140357563 | Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof - Compositions and methods for generating activated protein C and methods of use thereof are disclosed. | 12-04-2014 |